Sort by
Refine Your Search
-
, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core
-
Authority responses; participate in FDA, EMA, and PMDA meetings. Labeling & Core Documentation: Support development and maintenance of the Investigator’s Brochure, protocols, ICFs, and global product
-
delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce
-
and post-approval pull-through by partnering closely with the broader multi-functional USMA team including market access operations, pricing and contracting, analytics, and field teams. Additionally
-
breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation
-
delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce
-
medical content review for professional materials and key advocacy initiatives. · With oversight from the MSLs, participate in Core Teams, providing clinical insights for product development and
-
core marketing principles, commercial operations, and/or business processes. They will understand our healthcare providers and patients' needs and work cross-functionally to achieve business
-
developing competencies in core areas of MSA functions, such as Publications and Scientific Communications , Field Medical Affairs (Medical Science Liaison), Medical Information , Medical Education
-
culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business